Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens by Parobek, Christian M. et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
UMass Center for Clinical and Translational 
Science Supported Publications 
University of Massachusetts Center for Clinical 
and Translational Science 
2014-04-17 
Differing patterns of selection and geospatial genetic diversity 
within two leading Plasmodium vivax candidate vaccine antigens 
Christian M. Parobek 
University of North Carolina at Chapel Hill 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/umccts_pubs 
 Part of the Biodiversity Commons, Bioinformatics Commons, Computational Biology Commons, 
Genomics Commons, Immunity Commons, Immunology of Infectious Disease Commons, 
Immunoprophylaxis and Therapy Commons, Infectious Disease Commons, Parasitic Diseases Commons, 
Parasitology Commons, and the Translational Medical Research Commons 
Repository Citation 
Parobek CM, Bailey JA, Hathaway NJ, Socheat D, Rogers WO, Juliano JJ. (2014). Differing patterns of 
selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine 
antigens. UMass Center for Clinical and Translational Science Supported Publications. https://doi.org/
10.1371/journal.pntd.0002796. Retrieved from https://escholarship.umassmed.edu/umccts_pubs/28 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in UMass Center for 
Clinical and Translational Science Supported Publications by an authorized administrator of eScholarship@UMMS. 
For more information, please contact Lisa.Palmer@umassmed.edu. 
Differing Patterns of Selection and Geospatial Genetic
Diversity within Two Leading Plasmodium vivax
Candidate Vaccine Antigens
Christian M. Parobek1,2*, Jeffrey A. Bailey3,4, Nicholas J. Hathaway3,5, Duong Socheat6,
William O. Rogers7, Jonathan J. Juliano8
1 School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America, 2Curriculum in Genetics and Molecular Biology, University of
North Carolina, Chapel Hill, North Carolina, United States of America, 3 Program in Bioinformatics and Integrative Biology, University of Massachusetts, Worcester,
Massachusetts, United States of America, 4Division of Transfusion Medicine, School of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts,
United States of America, 5 School of Medicine, University of Massachusetts, Worcester, Massachusetts, United States of America, 6National Malaria Center, Phnom Penh,
Cambodia, 7United States Navy, Naval Medical Research Unit #2, Phnom Penh, Cambodia, 8Division of Infectious Diseases, University of North Carolina School of
Medicine, Chapel Hill, North Carolina, United States of America
Abstract
Although Plasmodium vivax is a leading cause of malaria around the world, only a handful of vivax antigens are being
studied for vaccine development. Here, we investigated genetic signatures of selection and geospatial genetic diversity of
two leading vivax vaccine antigens – Plasmodium vivax merozoite surface protein 1 (pvmsp-1) and Plasmodium vivax
circumsporozoite protein (pvcsp). Using scalable next-generation sequencing, we deep-sequenced amplicons of the 42 kDa
region of pvmsp-1 (n = 44) and the complete gene of pvcsp (n = 47) from Cambodian isolates. These sequences were then
compared with global parasite populations obtained from GenBank. Using a combination of statistical and phylogenetic
methods to assess for selection and population structure, we found strong evidence of balancing selection in the 42 kDa
region of pvmsp-1, which varied significantly over the length of the gene, consistent with immune-mediated selection. In
pvcsp, the highly variable central repeat region also showed patterns consistent with immune selection, which were lacking
outside the repeat. The patterns of selection seen in both genes differed from their P. falciparum orthologs. In addition, we
found that, similar to merozoite antigens from P. falciparum malaria, genetic diversity of pvmsp-1 sequences showed no
geographic clustering, while the non-merozoite antigen, pvcsp, showed strong geographic clustering. These findings
suggest that while immune selection may act on both vivax vaccine candidate antigens, the geographic distribution of
genetic variability differs greatly between these two genes. The selective forces driving this diversification could lead to
antigen escape and vaccine failure. Better understanding the geographic distribution of genetic variability in vaccine
candidate antigens will be key to designing and implementing efficacious vaccines.
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Introduction
Plasmodium vivax causes 80 to 300 million infections per year and
over 2.5 billion people remain at risk of infection despite malaria
elimination efforts [1]. Now, concern over P. vivax is growing due
to reports of increasingly severe disease [2], emerging chloroquine
resistance [3], and multi-drug resistance [4]. Ultimately, an
effective vaccine will be important for controlling P. vivax malaria
[5]. The fact that humans naturally develop partial immunity to P.
vivax and P. falciparum lends hope for effective vaccines against
these parasites; however, because the majority of global malaria
research funding targets P. falciparum [6,7], only a handful of P.
vivax antigens are currently being considered for vaccine develop-
ment [8]. Among these are P. vivax merozoite surface protein 1
(pvmsp-1) and circumsporozoite protein (pvcsp).
PvMSP-1, an erythrocytic vaccine candidate, plays an impor-
tant role in reticulocyte invasion [9]. Its C-terminus contains a
42 kDa region, which is processed into 33 and 19 kDa fragments
(Figure 1A). The 33 kDa fragment contains two high-affinity
reticulocyte binding clusters (HARBs) (20 kDa and 14 kDa), and
antibodies against the HARBs confer protection in monkeys [10].
In humans, antibodies to the 42 kDa region have also been
associated with clinical protection, making this region an attractive
vaccine candidate [11–14]. Another vivax protein, PvCSP, is a
pre-erythrocytic vaccine candidate and is critical in sporozoite
motility and hepatocyte invasion [15]. P. vivax circumsporozoite
protein has an immunogenic central repeat, consisting of two
major types of nonapeptide repeats (VK210 and VK247 – there is
also a rarer repeat type termed vivax-like) flanked by highly
conserved 59 and 39 regions (Figure 1B). The P. falciparum
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ortholog of pvcsp, as formulated in RTS,S, is the most advanced P.
falciparum vaccine candidate to date, showing modest efficacy at
one year interim analysis in a Phase III trial [16].
Despite this knowledge of PvMSP-1 and PvCSP, little is known
about the geospatial genetic diversity of these antigens. Variation
in these antigens may become a mechanism of vaccine resistance if
strain-specific immunity is important in protection, as has been
seen in some P. falciparum vaccine candidates [17]. Vaccine trials of
P. falciparum AMA1 and MSP2 as well as genetic crosses using P.
chabaudi underscore the importance of strain-specific immunity as a
determinant of outcome [18–21]. Additionally, despite initial
evidence that strain-specific immunity may not impact RTS,S
efficacy [22–25], the incomplete protection afforded by the RTS,S
vaccine in Phase II and III trials [16,26,27] has prompted a careful
examination of strain-specific responses to this vaccine. Thus, as
momentum grows for field trials of P. vivax vaccine antigens,
carefully designed population genetic studies of P. vivax vaccine
candidates will be key to assess the need for multivalent vaccine
formulations.
To better understand the selective forces on, and geospatial
genetic diversity associated with pvmsp-1 and pvcsp, we used the
Illumina sequencing platform to determine haplotypes for 42 kDa
region of pvmsp-1 (n = 44) and we used the PacBio and Illumina
platforms to sequence the complete pvcsp gene (n = 47) from
Cambodian isolates [28]. To dissect the immune selection acting
on these regions, we studied these sequences using population
genetic tests of selection and models of tandem repeat evolution.
To evaluate the global genetic diversity of pvmsp-1 and pvcsp, we
extracted worldwide pvmsp-1 and pvcsp sequence data available in
GenBank (n = 238 for pvmsp-1 and n = 412 for pvcsp) (Figure S1),
and studied our sequence data alongside the sequences from
GenBank msp-1. Finally, we compare the performance of Illumina
and PacBio sequencing to traditional Sanger sequencing, and
discuss the potential and challenges of next-generation sequencing
for population genetic studies of malaria parasite antigens.
Figure 1. Protein domains and immunologically-relevant regions of pvmsp-1 42 kDa region and pvcsp. For both genes, numbers
indicate coordinates according to the Sal1 reference genes. Sequences for pvmsp-1 (PVX_099980) and pvcsp (PVX_119355) were accessed August 14,
2012 from PlasmoDB.org. (A) The pvmsp-1 42 kDa region is composed of two primary subunits – a 33 kDa and a 19 kDa subunit. Other sub-regions,
including the 20 kDa and 14 kDa HARBs have been previously defined and studied. Here, we define the region between the HARBs as the
‘‘intervening region.’’ (B) The pvcsp gene is composed of three regions – an N-terminal non-repeat region, a central repeat region, and a C-terminal
non-repeat region. The central repeat region consists of two major nonapeptide repeat types, termed VK210 and VK247. Approximate locations of
pvcsp regions I and II are noted with horizontal lines in the N- and C-terminal non-repeat regions, respectively.
doi:10.1371/journal.pntd.0002796.g001
Author Summary
Plasmodium vivax causes tens of millions of malaria cases
each year. Although some vaccines against P. vivax are
being developed, little is known about the geospatial
genetic diversity and selective constraints of the parasite
surface antigens that these vaccines target. In order to
create vaccines that are both efficacious and useful in
diverse regions of the world, the strain diversity of these
potential vaccine targets must be well understood.
Specifically, we must understand whether and how the
human immune system develops immunity against these
antigens as well as understanding whether these antigens
are similar in geographically diverse parasite populations.
Here, using next-generation sequencing and population-
genetic analyses, we found evidence of likely immune
selection in specific regions of two leading vivax vaccine
candidate antigens, PvMSP-1 and PvCSP. At the pvmsp-1
locus, we also found more genetic variability within
populations than between populations, with some DNA
sequences from geographically diverse populations being
highly similar. In contrast, pvcsp sequences from geo-
graphically diverse populations are very distinct from one
another, with specific sequence patterns occurring in
certain geographic regions. Our findings provide new
insights into the geographic genetic diversity of these two
antigens and can help inform the development of effective
P. vivax vaccines.
Selection and Diversity in P. vivax Antigens
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Methods
Parasite isolates
Clinical samples from a previous study were used for this study
[29]. Written informed consent was acquired from each
individual and the study was approved by the IRB at University
of North Carolina, the IRB of the Naval Medical Research Unit
#2, Jakarta, Indonesia, and the Cambodian National Ethical
Committee for Health Research. Briefly, blood spots were
collected from 109 patients with uncomplicated vivax malaria,
presenting to a clinic in Chumkiri, Cambodia during 2006–07.
We selected 48 subjects with a multiplicity of infection (MOI) of
one (n = 20) or two (n = 28) for sequencing. MOI was determined
by heteroduplex tracking assay (HTA) [28,30]. Briefly, in an
HTA, radiolabeled DNA probes are annealed to genomic DNA
and drawn through a non-denaturing gel matrix. The number of
bands observed represents the number of conformation differ-
ences present among heteroduplexes, and is a proxy for the
number of infection clones (MOI). Details of the method have
been published elsewhere [31].
Amplification of pvmsp-1 and pvcsp
The pvmsp-1 42 kDa region (nucleotides 3973–5239 of Sal1
PVX_099980, www.PlasmoDB.org) was amplified using primers
F: 59-CAG GAC TAC GCC GAG GAC TA-39 and R: 59-GGA
GGA AAA GCA ACA TGA GC-39 and an Eppendorf
Mastercycler (Eppendorf, Hauppauge, NY) in 50 mL reactions
containing 5 mL 106 Qiagen Hotstar Master Mix (Qiagen,
Valencia, CA), 0.25 mL Qiagen Hotstar Taq, 300 nM forward
primer, 300 nM reverse primer, 1 mL 10 mM dNTPs, and 5 mL
5–10 mM template. Cycling conditions were: 95uC615 m; 35
cycles of 95uC645 s, 55uC645 s, 72uC63 m; and 72uC610 m.
The pvcsp gene (PVX_119355) was performed by nested PCR. The
outer step used primers F: 59-GGC AAA CTC ACA AAC ATC
CA-39 and R: 59-TGC GTA AGC GCA TAA TGT GT-39.
Reactions were as above except for 600 nM forward primer,
600 nM reverse primer, 1 mL 10 mM dNTPs, 5 mL 5–10 mM
template, 6 mL of 25 mM MgCl2, and 28.75 mL H2O. Cycling
conditions were: 95uC615 m; 25 cycles of 95uC645 s,
45uC645 s, 72uC63 m; and 72uC610 m. The inner step used
600 nM of each of the primers F: 59-AAA CAG CCA AAG GCC
TAC AA-39 and R: 59-GAC GCC GAA AAT ATT GGA TG-39
using 5–10 mL of the initial amplification. The cycling conditions
were: 95uC615 m; 25 cycles of 95uC645 s, 54uC645 s,
72uC63 m; and 72uC610 m.
Amplicon sequencing and sequence determination
pvmsp-1 and pvcsp amplicons were fragmented by acoustic
shearing (Covaris, Woburn, MA) using the following settings: 10%
duty cycle, 5.0 intensity, 200 cycles per burst, and frequency
sweeping mode. Forty-eight barcoded libraries were prepared
using the NEXTflex multiplex library kit (Bioo Scientific, Austin,
Texas), each containing the pooled pvmsp-1 and pvcsp amplicons
from one patient. Libraries were sequenced on the Illumina
HiSeq2000, using the paired-end 100 base pair chemistry
(Illumina, San Diego, CA).
We used Lasergene SeqMan NGen v.3.1.1 (DNASTAR,
Madison, WI) to assemble pvmsp-1 short reads de novo and to
determine SNP frequency within each assembly. For purposes of
comparison and confirmation, we re-sequenced 9 pvmsp-1
amplicons with differing MAFs: 3 samples with all MAFs.90%;
3 samples with all MAFs between 60% and 90%; 3 samples with
MAF,60% for at least one SNP. Sanger-sequence haplotypes
were compared to predicted Illumina haplotypes. Based on these
comparisons, only predicted pvmsp-1 haplotypes with MAF.60%
at all polymorphic sites were used in our analysis.
In addition to Illumina sequencing, pvcsp amplicons were
sequenced using PacBio Circular Consensus Sequencing (Pacific
Biosciences, Menlo Park, CA). One PacBio SMRT cell produced a
total of 12103 reads with a minimum of 36 circular consensus
coverage, which were used for this study. These were further
filtered, removing truncated reads or reads with errors in the
barcode. This left 8430 reads (3979 forward and 4451 reverse).
Clustering attempted to minimize false positive haplotypes due to
erroneous base calls and PCR slippage within the tandem repeat
region. For each sample, haplotypes were created by clustering
reads, allowing reads differing only by indels of 1 and 2 bases and
low quality mismatches to collapse. Low quality was defined as
either a mismatching base Q,30 or any Q,25 within an 11
basepair region centered on the mismatch, as has been applied
previously to rigorous SNP discovery from shotgun data [32]. To
overcome artifacts of PCR infidelity due to slippage events leading
to shortened repeats and false haplotypes, we set a high threshold
requiring that co-occurring haplotypes of the same repeat type be
at high frequency in order to exclude the low frequency variation/
stuttering in the repeat region. Haplotype repeat type was then
determined by translation and the most frequent haplotype of each
major repeat type (VK210 and VK247) present was kept .0.5%.
Additional haplotypes of major repeat types were kept if they were
common (.20%) and thus unlikely to be due simply to low
frequency slippage events. In total across all samples 4081 of the
8430 reads clustered contributed to utilized haplotypes.
The long-read haplotypes determined through consensus
clustering were used as templates for short-read alignment using
Bowtie2 v 2.1.0 [33], with very-sensitive alignment parameters and
stringent filtering for Mapping Quality Score and Alignment
Score. Final sequence predictions were used for the analyses in this
paper and were deposited in GenBank under accession numbers
JX461243-JX461285 and KJ173797- KJ173802 for pvcsp, and
JX461286-JX461333 for pvmsp-1.
Rarefaction curves of haplotypes were calculated using
EstimateS v9.0. Individual-based curves using sampling without
replacement were estimated [34] and extrapolated to 26 the
actual sample number [35]. Rarefaction plots were visualized in
the R base package (http://cran.us.r-project.org/).
Acquisition of published sequences for inter-population
comparisons
GenBank was queried for population sets published prior to
August 1, 2013, which included sequence data for the 42 kDa
region of pvmsp-1 and the whole-gene of pvcsp. Sequences from a
recent publication [36] were excluded because the isolates were
collected over the course of a 12 year period. The authors provide
evidence that the haplotype distribution of this population
changed substantially over time, making this population inappro-
priate for our analysis of selection.
Assessing selection on pvmsp-1 and pvcsp
Population datasets with .25 sequences that were collected
over a span of#4 years were included for analysis of selection. We
used DnaSP v5.1 to perform tests of selection [37]. We calculated
polymorphism and Tajima’s D across pvmsp-1 and the pvcsp
constant regions using a 50 bp sliding window with a 25 bp step
size. We also performed 1000 coalescent simulations with
recombination to determine a 95% confidence interval and centile
for each Tajima’s D estimate [38]. To test for long-term selection,
we used the McDonald-Kreitman (MK) test [39]. Skew was
calculated using Fisher’s exact test (two tailed). For the pvmsp-1
Selection and Diversity in P. vivax Antigens
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42 kDa region amplicons reported here and by others, 15
Plasmodium knowlesi pkmsp-1 isolates from Thailand [40] (Accession
Nos. JF837339-JF837353) were used as the interspecies outgroup.
Three insertions and deletions occurred in the 42 kDa region of
pvmsp-1 relative to pkmsp-1, and were not considered. We could not
obtain MK estimates for pvcsp sequences due to numerous
insertions and deletions relative to pkcsp.
For analysis of pvcsp repeats, we performed pairwise compar-
isons of untranslated repeat units within individual pvcsp
sequences [41]. We calculated skewness and mean nucleotide
differences between repeat units, as previously reported [42].
Similar to the methods of Dias et al., 2013, we also calculated
dN/dS on the first 1–459 bases of all 32 VK210 repeat regions
and the first 1–540 bases of all 15 VK247 repeat regions. This
analysis was performed in MEGA5, using the Nei-Gojobori
method [43].
Phylogenetics and statistics to determine population
structure
Interpopulation heterogeneity was first assessed using Wright’s
fixation index (FST). Pairwise fixation values between pvmsp-1
populations were calculated in DnaSP. Site-specific fixation values
for pairwise comparisons among Cambodia, NW Thailand, S
Thailand, India, and Turkey were generated using the analysis of
molecular variance (AMOVA) function within Arlequin v3.11
[44].
Neighbor-joining trees for pvmsp-1, pvcsp VK210, and pvcsp
VK247 were drawn using the APE package for R [45]. To
generate trees based off pvmsp-1, distance calculations between
haplotypes were performed in MEGA5 using the maximum
composite likelihood method to construct a neighbor-joining
tree file. For the pvcsp CR, we used MS_Align (v.2.0) [46,47] to
create genetic distance matrices separately comparing both the
VK210 and VK247 repeat arrays. MS_Align generates an
event-based genetic distance using a model of tandem repeat
evolution (expansion, deletion, substitution). Cost parameters
for MS_Align were set to 0.1 for amplification or contraction
and 5 for repeat insertion or deletion. A pairwise cost table of
repeat-to-repeat mutations was created in MEGA5 using the
maximum composite likelihood method and used as input for
MS_Align [41,48]. MS_Align output matrices were used by
FastME [49,50] to construct neighbor-joining trees with
balanced branch-length estimation.
To cluster geographic groups, we calculated Hudson’s
nearest-neighbor statistic (SNN) [51]. Input was in the form
of a pairwise distance matrix between all haplotypes for each
phylogeny. For this statistic, highly distant populations have
values approaching 1 while panmictic populations have values
near 0.5. To test the reproducibility of the geographic
clustering predicted by SNN, 1000 jackknife samplings were
constructed for both pvmsp-1 and pvcsp VK210 and VK247
populations using Fast UniFrac [52]. For each jackknife
replicate, 5 individuals, based on the size of the smallest
population, were randomly selected from each population and
used to redraw trees. Observed splits between geographic
populations were quantified and used to assign confidence to
predicted geographic clusters. To evaluate potential mutation-
al paths connecting all pvmsp-1 haplotypes, we constructed a
median-joining network using NETWORK v4.6 (Fluxus
Engineering, Suffolk, England) [53]. This method expresses
multiple plausible evolutionary paths in the form of cycles. A
similar analysis was not completed for pvcsp due to the variable
length of CR haplotypes.
Results
pvmsp-1 sequences
We Illumina sequenced pvmsp-1 42 kDa-fragments (Figure 1A)
from 48 patients, and compared these to Sanger sequencing data
for selected samples. Illumina haplotypes with a major allele
frequency of .60% agreed with Sanger haplotypes in every case
tested (n = 6). Illumina haplotypes with a major allele frequency of
,60% did not consistently agree with Sanger haplotypes (n = 3).
Thus, we were able to build 44 complete pvmsp-1 42 kDa
haplotypes (26 unique haplotypes) with a major allele frequency
of.60% at all polymorphic sites (Table 1). The average coverage
depth for all isolates was .800 reads per base, with all bases
having $100 reads of coverage. Haplotype accumulation (rare-
faction) curves were estimated, and then further extrapolated to
show that our sample captured fewer than half the total pvmsp-1
haplotypes in this region of Cambodia (Figure 2). In addition to
these isolates, we identified 238 submissions in GenBank [54–58]
(Table S1) containing either the whole-gene or 42 kDa-region
sequence information.
Detecting signatures of selection within pvmsp-1
The interaction between human host and the parasite has
had a profound impact on the parasite genome, leaving behind
characteristic ‘‘signatures’’ of natural selection [59], which are
detectable using population genetics approaches to examine
sequence diversity. We first assessed nucleotide diversity
(Figure 3A), and observed a spike of polymorphism in the
region between the two HARBs (positions 4348–4731 in the
Sal1 reference). We termed this the ‘‘intervening region’’. To
test whether the diversity in the intervening region is due to
long-term selection, we used the McDonald-Kreitman (MK)
test [39] to compare the ratio of non-synonymous to
synonymous nucleotide polymorphisms between the Cambo-
dian P. vivax population and a Thai P. knowlesi population [40].
We observed a highly elevated MK ratio (p = 0.00427) in the
intervening region but not in the HARBs (data not shown) or
the entire 42 kDa region (p = 0.681), suggesting that the
intervening region is under long-term selective pressure
(Table 2).
To determine whether the long-term selective pressure shaping
the intervening region is potentially due to human immunity, we
assessed balancing selection in this region, as balancing selection
within a malaria antigen suggests that the antigen is a target of the
human immune system [59]. We applied Tajima’s D test of
neutrality [60] to five geographically distinct P. vivax populations
(all populations with n.25, accounting for 190 of 238 available
sequences) (Table 1, Figure 3B). In panmictic populations with
an uncomplicated demographic history [59], the Tajima’s D
statistic can indicate whether a nucleotide sequence is under
directional (D,0) or balancing selection (D.0). Populations not
subjected to recent bottlenecks (i.e. Cambodia, India, and NW
Thailand, [54,58]) demonstrated a significant signature of
balancing selection in the pvmsp-1 42 kDa region (Table 1). This
signature occurred specifically in the intervening region
(Figure 3B), and is consistent with the conclusion that human
immunity targets the intervening region.
The three regions of the pvmsp-1 fragment that are considered
vaccine candidates were each assessed for diversity in the
Cambodian population [9,61]. In contrast to the intervening
region, the 20 kDa HARB (Sal1 positions 4021–4347) and 14 kDa
HARB (Sal1 positions 4732–4941) showed no coding polymor-
phisms and no evidence of balancing selection, similar to recent
reports [61]. The 19 kDa fragment (Sal1 nucleotide positions
Selection and Diversity in P. vivax Antigens
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4918–5239) also showed limited diversity, with only a K1709E
substitution, and no evidence of balancing selection.
Geospatial genetic diversity at the pvmsp-1 42 kDa
region
Although the pvmsp-1 42 kDa region contains potential vaccine
candidates [9,61], the 42 kD region’s global genetic diversity has
not been carefully evaluated. To study pvmsp-1 42 kDa diversity,
we calculated Wright’s Fixation index (FST) [62] for each pairwise
comparison between five diverse populations (Table 3). FST
values between naturally evolving parasite populations (Cambodia,
NW Thailand, and India) approached zero, showing a high degree
of genetic similarity, while comparisons with populations that have
undergone a recent bottleneck (S Thailand and Turkey) showed a
high degree of genetic distance due to their limited number of
haplotypes. Similarly, FST values calculated for each variable site
demonstrate a high degree of homogeneity in pairwise compar-
isons between the Cambodia, NW Thailand, and India popula-
tions across all sites, and substantial heterogeneity between S
Thailand and Turkey across all sites (Figure S2). This is evidence
that balancing selection maintains a similar range of alleles in the
pvmsp-1 42 kDa region of multiple geographically diverse naturally
evolving P. vivax populations.
To visualize whether 42 kDa sequences cluster according to
geography, we compared all unique haplotypes in a single
neighbor-joining tree, which revealed little clustering according
to geographic origin (Figure 4). We quantified the extent of this
clustering using Hudson’s nearest-neighbor statistic (SNN), which
assesses how frequently a variant’s nearest neighbor is from the
same population [51]. In both global and pairwise comparisons,
pvmsp-1 42 kDa sequences from naturally evolving populations in
Cambodia, India, and NW Thailand showed no evidence of
strong geographic clustering (Table 4). To further confirm this
finding, a neighbor-joining consensus tree was created and
underwent 1000 jackknifed replicates (Figure 5A). Results showed
that the predicted splits between most populations occurred only
less than 50% of the time, providing strong evidence that there is
minimal geographic clustering of pvmsp-1 42 kDa sequences.
To better understand the evolutionary relationships between
pvmsp-1 haplotypes from around the world, we employed a
median-joining network to describe the set of potential mutational
paths between all available global pvmsp-1 42 kDa sequences [53].
The network shows extensive admixture of parasite populations
from diverse locales, with numerous mutational paths connecting
haplotypes (Figure 6). With the exception of populations from S
Thailand and Turkey, which have undergone recent bottlenecks,
these data provide further evidence that there is no clustering by
geography.
pvcsp sequences
We sequenced the complete pvcsp gene from 43 isolates using the
PacBio and Illumina platforms. de novo assembly of the Illumina
paired-end short reads was not possible, due to over-collapse in the
central repeat (CR) region, resulting in inappropriately short CRs.
In contrast, PacBio long reads allowed the gene to be sequenced in
its entirety and, after clustering, predicted 47 pvcsp haplotypes
within the 43 samples. Reported error rates for PacBio sequencing
have been high, especially for indels [63]; however, the use of
Circular Consensus Sequencing allows single DNA fragments to
be read multiple times, decreasing the error rate of the final
predicted sequence. To check the accuracy of PacBio pvcsp
haplotypes, individual haplotypes were used as a template for
alignment of Illumina reads from the same clinical isolate. The
addition of Illumina reads corrected only a single 1-bp deletion in
a single haplotype. Therefore, after clustering, PacBio-predicted
haplotypes have an error rate of 1/(,1200 basepairs/sequence
647 sequences), or approximately 0.002%.
Considering the entire gene, there were 24 unique haplotypes at
the nucleotide level, and most genetic diversity was within the CR
(Figure 1). Both nonapeptide repeat array types – VK210 (total
n = 32, range 17–21 repeat units) and VK247 (total n = 15, range
20–21 repeat units) – were represented in our Cambodian
Figure 2. Haplotype rarefaction curves for the Cambodian cohort. Calculated rarefaction curves are depicted by solid blue (pvmsp-1) and red
(pvcsp) lines. Dotted lines represent rarefaction values extrapolated according to the methods of Cowell, et al. The 95% CIs of rarefaction estimates for
pvmsp-1 and pvcsp are demarked by light blue and light red shaded areas, respectively.
doi:10.1371/journal.pntd.0002796.g002
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population, with no VK210–VK247 hybrids (reviewed in [64]).
The average Illumina short-read depth for each isolate was .
1000, with all bases having $5 reads of coverage. In addition to
our isolates, we identified one cohort of nearly complete pvcsp
sequences (n = 27), and 12 cohorts of CR sequences (n = 385) [65–
70] (Table 1). An extrapolated rarefaction curve showed that we
sampled more than two thirds of the pvcsp CR haplotypes in this
part of Cambodia, and that there are significantly fewer pvcsp CR
variants in this region of Cambodia than pvmsp-1 42 kDa variants
(Figure 2).
Detecting signatures of selection within pvcsp
In contrast to pvmsp-1, the 59 and 39 non-repeat regions of pvcsp
had no significant signatures of selection either by the MK test
(data not shown) or Tajima’s D test (Table 1). The 59 non-repeat
region in the Cambodian cohort showed a non-significant
Figure 3. Nucleotide diversity and Tajima’s D across the pvmsp-1 42 kDa region and the whole pvcsp gene. Polymorphism (nucleotide
diversity, p) (A) and Tajima’s D (B) were calculated across the pvmsp-1 amplicon for five diverse populations. A sliding window (50 bp window and
25 bp step size) was used to achieve a high resolution analysis. Grey hatches demark the intervening region (nucleotides 4348–4731). For pvcsp, N-
terminal and C-terminal non-repeat regions were analyzed for nucleotide polymorphism (C) and evidence of balancing selection (D) using a sliding
window. Putatively panmictic populations are marked with a solid line, while populations known to be subject to strong selective forces are marked
with dotted lines. All coordinates are based on Sal1 pvmsp-1 and pvcsp reference sequences.
doi:10.1371/journal.pntd.0002796.g003
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signature of balancing selection (Table 1 and Figure 3D), which
was due to a G38N amino acid polymorphism. This polymor-
phism also was observed in 6/16 parasites from the Latin Pacific
region (JQ511263-JQ511276, JQ511279, JQ511286) and 2/27
parasites from Colombia (GU339072 and GU339085). The 39
non-repeat region had little evidence of balancing selection, with
Tajima’s D values ,0 (Table 1 and Figure 3D). Within pvcsp,
an 18 amino-acid C-terminal motif known as Region II (amino
acid residues 311–328 in Sal1) is important for parasite invasion of
hepatocytes [71] and purportedly contains both B and T-cell
epitopes [72,73]. Among all Cambodia and Colombia parasite
isolates, this motif is completely conserved at the nucleotide and
protein level, with an amino-acid sequence of EWTPCS
VTCGVGVRVRRR, similar to previous reports [61].
To better understand the selective forces acting upon the pvcsp
CR, we assessed the dN/dS ratio for Cambodian VK210 and
VK247 [66]. Strikingly, synonymous substitutions were strongly
favored in both VK210 (dN/dS = 0.267; Z test p,0.001) and
VK247 (dN/dS = 0.166; Z test p,0.001) repeats. This is consistent
with the finding that VK210 and VK247 isolates from around the
world consistently demonstrate a depressed dN/dS ratio, suggest-
ing that the VK210 and VK247 repeat regions are both under
strong purifying selection [66].
The CR of P. falciparum csp is thought to evolve by slipped-strand
mispairing [42]. To understand if a similar mechanism works in
the pvcsp repeats, we studied the mismatch distribution of pairwise
genetic distances between untranslated repeat units within each
VK210 and VK247 repeat array type in Cambodia. Consistent
with another study [68], we observed a strong right skew in the
proportion of genetic differences between pairwise VK210 repeat
comparisons, and between pairwise VK247 repeat comparisons,
evidence that pvcsp repeats have a high proportion of identical or
nearly identical repeats (data not shown). This finding is consistent
with a continuous and rapid expansion and contraction of repeats
by slipped-strand mispairing, which may be a mechanism to evade
host immunity [42].
Geospatial genetic diversity at the pvcsp central repeat
A recent study assessed global genetic diversity in the pvcsp CR,
but did not define the correlates of differentiation between
populations [66]. Moreover, this report investigated CR diversity
by using a subset of the repeat region that was invariant in length.
This approach may not reflect true population structure as it only
assesses repeats early in the CR. Indeed, we have found that
certain repeat types do cluster in locations within the repeat arrays
(data not shown).
To more rigorously study the global diversity of the pvcsp
CR, we modeled CR repeat expansion, contraction, and
substitution using MS_Align, which calculates an event-based
genetic distance between CR haplotypes [46]. From these
data, we constructed neighbor-joining trees for global VK210
and VK247 repeat arrays isolates (Figures 7–8). In contrast to
pvmsp-1, the VK210 and VK247 trees revealed striking
geographic clustering by country and continent. We quantified
clustering using Hudson’s SNN, and observed strong genetic
differentiation between most geographically diverse parasite
populations, in contrast to pvmsp-1 (Table 4). To confirm this
finding, neighbor-joining consensus trees for both VK210 and
VK247 were subjected to 1000 jackknife replicates and the
reproducibility of predicted splits between populations was
tested demonstrating a strong correlation between genetic
distance and geography (Figure 5B–C).
Table 2. McDonald-Kreitman test for selection in pvmsp-1.
McDonald-Kreitman Comparisons
42 kDa region 42 kDa intervening region
Synonymous Non-synonymous Synonymous Non-synonymous
Fixed 96 93 32 28
Polymorphic 34 39 10 31
p= 0.681 p= 0.00427
Evidence for long-term selective pressure on the pvmsp-1 42 kDa region and the 42 kDa intervening region was assessed with the McDonald-Kreitman test, using P.
knowlesi msp1 as the outgroup comparator. A Fisher’s exact test (two tailed) was used to determine significance.
doi:10.1371/journal.pntd.0002796.t002
Table 3. Interpopulation F-statistics for pvmsp-1.
pvmsp-1 Global FST 0.340
pvmsp-1 Pairwise Cambodia India NW Thailand S Thailand
India 0.031
NW Thailand 0.000 0.043
S. Thailand 0.449 0.433 0.366
Turkey 0.361 0.329 0.403 0.796
FST values compare the relatedness of a gene among different populations of the same species. Reported values compare the relatedness of pvmsp-1 42 kDa alleles for
pairwise comparisons between Cambodia, India, NW Thailand, S Thailand, and Turkey. FST values approaching 0 indicate greater relatedness, while values approaching 1
indicate substantial inter-population variability. Global FST statistic calculated between all pvmsp-1 populations with n.25 indicates that relatively little genetic distance
exists between the sampled populations. However, pairwise comparisons demonstrate that some populations exhibit a high degree of genetic similarity (Cambodia and
India, for example) while other populations are more dissimilar (S Thailand and Turkey, for example).
doi:10.1371/journal.pntd.0002796.t003
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We were able to define the peptide sequence basis of the
clustering observed among pvcsp CR repeats. For VK210 repeats,
almost all (81/84) Latin American repeat arrays contained either a
59 (GDRADGQPA)4 or an internal (GDRADGQPA)3–4, while
very few (11/278) of the Asian sequences contained one or both of
these features. Similarly, for VK247 repeat arrays, all (34/34)
Latin American sequences began with a single EDGAGDQPG
repeat, while only one (1/44) Asian sequence began with this
repeat. These sequence features may represent a reliable method
to assign sequences to a geographic region.
Discussion
This study (1) presents the first population set of pvmsp-1 and
pvcsp sequences from Cambodia, (2) identifies a signature of
putative immune-mediated, frequency-dependent selection in the
pvmsp-1 42 kDa region and the pvcsp CR, and (3) provides the most
comprehensive evaluation to date of geospatial genetic diversity for
these genes. We also demonstrate the feasibility of using a next-
generation sequencing approach to study the genetic diversity of
malaria antigens.
A distinguishing feature of this study is the use of next-
generation sequencing methods to generate P. vivax amplicon
sequence data from clinical isolates. This work represents a first
step into this largely unexplored territory. As a relatively
new technology, next-generation sequencing methods must be
validated before use in molecular epidemiological studies. We
provide evidence that the dominant Illumina-predicted pvmsp-1
haplotypes are consistent with Sanger sequencing, and are fit for
comparison with population sets generated by traditional sequenc-
ing methods. Methods for predicting multiple haplotypes from
short-read sequencing are under development and will need
further validation. We also demonstrate the ability of combined
PacBio-Illumina haplotypes to predict pvcsp VK210 and VK247
haplotypes out of individual mixed infections. As next-generation
sequencing methods are utilized more frequently for population
genetic studies of infectious diseases, the methods introduced here
will be further improved and will help to provide greater insight
into Plasmodia population genetics.
Evidence of selection in both pvmsp-1 and pvcsp
We found compelling genetic evidence that the pvmsp-1 42 kDa
intervening region is under strong immune pressure in multiple
panmictic populations. Results from the MK test suggested that
this region is under sustained selective pressure (Table 2);
however, because a positive MK test can signify balancing
selection or weak negative selection [74,75], we tested the
hypothesis that this region is under balancing selection using
Tajima’s D test of neutrality. Since multiple populations showed
strong evidence of balancing selection by Tajima’s D (Table 1,
Figure 3B), we conclude that the intervening region is
undergoing continual diversifying, balancing selection. An alter-
Figure 4. Neighbor-joining tree of 42 kDa regions from pvmsp-1 isolates. All unique 42 kDa haplotypes from each pvmsp-1 population set
with n.25 were plotted on a single unrooted, neighbor-joining phylogenetic tree. The Sal1 reference sequence is marked in grey.
doi:10.1371/journal.pntd.0002796.g004
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Figure 5. Jackknifed consensus trees demonstrate reproducible geographic clustering in pvcsp VK210 and VK247 isolates, but not
pvmsp-1. The reproducibility of population clustering was assessed using 1000 jackknifed phylogenies. Individual populations clustered together or
apart in each of the 1000 jackknifed phylogenies, and the frequency of a split between any two populations was quantified. Populations with grey
bars (,50% splits) were genetically similar, while populations with red bars (.99.9% splits) were highly genetically distinct. Phylogenies were built
from the pvmsp-1 42 kDa region (A), the pvcsp VK210 central repeat (B), and pvcsp VK247 central repeat (C).
doi:10.1371/journal.pntd.0002796.g005
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native hypothesis is that the positive Tajima’s D values are an
artifact of recent population contractions. Because (1) a positive
Tajima’s D was observed in multiple populations, and (2) other
regions of pvmsp-1 contained negative Tajima’s D values, we
conclude that the 42 kDa intervening region of pvmsp-1 undergoes
frequency-dependent (and likely immune-mediated) balancing
selection.
Because PvMSP-1 is a merozoite surface antigen, it is highly
accessible to antibodies and complement. The predicted structure
of the 42 kDa region shows that the 33 kDa fragment covers the
19 kDa fragment [11,76], limiting its exposure to the human
immune system relative to the 33 kDa fragment. This observation
could explain the extensive balancing selection present in the
33 kDa fragment (specifically, the intervening region) but not in
the 19 kDa fragment. Additionally, this finding suggests that the
sliding window approach for evaluating polymorphism and
balancing selection may help generate hypotheses about function-
ally important (19 kDa fragment, for example) or immunologically
dominant (the intervening region, for example) regions of P. vivax
proteins.
For pvmsp-1, Tajima’s D and FST were inversely correlated.
Populations with strong evidence of high Tajima’s D in the pvmsp-1
intervening region showed a low genetic differentiation by FST.
This suggests that in naturally evolving populations, diversification
of this region is extensive and maintains a similar range of genetic
diversity despite geographic distance. Populations that have
undergone a recent bottleneck show a low Tajima’s D with
relatively few variants and strong genetic differentiation from more
diverse populations. This suggests that if strain-specific immune
responses are important in vaccine efficacy, vaccines may work
more effectively if other interventions can be used to bottleneck the
population, thus decreasing its genetic diversity [54].
The central repeat region (CR) is a primary immunodominant
region of PvCSP. Though alignment-based methods to assess for
selection (Tajima’s D, for example) cannot be employed in a
tandem repeat region, there is wide-ranging evidence that selective
pressures shape the genetic composition of the pvcsp CR [77–81],
including new evidence hinting that hosts develop strain-specific
immunity to P. falciparum NANP repeats of varying lengths [82].
Indeed, the presence of two distinct repeat types (VK210 and
VK247) may itself be evidence of selection as suggested in a study
of the P. cynomolgi csp CR [80].
Our analysis of the two CR array types, VK210 and VK247,
also suggests that selection is occurring in this region. In pairwise
comparisons of nucleotide and amino acid differences we observed
a positive skew showing decreased differences among repeat units.
This finding is consistent with Patil et al.’s study of pvcsp isolates
from Brazil [68], and provides further evidence that both VK210
Figure 6. Median-joining network of diverse pvmsp-1 populations proposes multiple mutational paths between geographically
diverse populations. 286 pvmsp-1 42 kDa sequences from diverse geographical regions were used as input to create an unrooted median-joining
network. This network is a visual representation of the mutational paths that may explain the observed sequence diversity. Each node represents an
allele, node size represents the frequency of that allele (range n= 1 to n= 54), and node color corresponds to country of origin. Cycles within the
diagram represent alternative evolutionary pathways. Corners represent obligate intermediate sequences that were not observed among the
sampled alleles. Line length is not proportional to genetic distance.
doi:10.1371/journal.pntd.0002796.g006
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and VK247 repeat arrays may continuously evolve via slipped-
strand mispairing [42]. Furthermore, consistent with a recent
study of selection in worldwide pvcsp isolates [66], we found that
Cambodian pvcsp VK210 and VK247 isolates have a strong bias
toward synonymous substitutions. This signature of purifying
selection is consistent with reports from pfcsp [83–85] and suggests
that there are a limited number of amino acid polymorphisms
allowable within this repeat region. Taken together, these findings
suggest that expansion, contraction, and rearrangement of repeat
units, rather than generation of novel repeat units through
mutation, maintain genetic diversity at the pvcsp locus in both
VK210 and VK247 variants. This phenomenon may be
responsible for immune evasion [68,86].
Although these two vivax genes are orthologs of well-charac-
terized vaccine candidate antigens from P. falciparum malaria,
substantial differences are seen in the effects of immune selection
between these genes and their orthologs. Previous reports have
shown that the functionally similar pfmsp-1 42 kDa fragment has
relatively low nucleotide diversity and lacks evidence of balancing
selection by Tajima’s D [87]. pfcsp, on the other hand, shows a
high level of nucleotide diversity [88–90] and modest Tajima’s D
elevations in the C-terminal T cell epitopes [88,91]. These
patterns are in stark contrast to our observations in P. vivax, and
this highlights the need for P. vivax-specific studies to determine
appropriate candidate vaccine antigens.
Finally, our analysis of the pvmsp-1 42 kDa region underscores
the importance of selecting an appropriate parasite population for
population-genetic studies. We did not observe signatures of
balancing selection in pvmsp-1 populations from S Thailand or
Turkey. This is likely due to bottlenecks secondary to robust
malaria control measures employed in S Thailand [54] and limited
human migration in Turkey [58]. Thus, appropriate selection of
panmictic populations for these studies is critical.
Differing patterns of geospatial genetic diversity at
pvmsp-1 and pvcsp
Using both tree-based and statistical methods [92], we found
that pvcsp, but not pvmsp-1, showed strong clustering by geography
(Tables 3–4 and Figures 4–8). For pvmsp-1, we observed little
geographic clustering among naturally evolving parasite popula-
tions, suggesting that immune selection maintains similar pvmsp-1
alleles around the globe. Notably similar findings have been
described in Duffy Binding Protein and Thrombospondin-related
anonymous protein in vivax malaria [61], while a recent global
survey of diversity in the Apical Membrane Antigen 1 found
evidence of geographically restricted haplotypes [93]. In contrast
Figure 7. Neighbor-joining tree of pvcsp VK210 repeat arrays. All unique repeat array haplotypes from each pvcsp VK210 population set were
plotted on a single unrooted, neighbor-joining phylogenetic tree. Visual inspection reveals strong geographic clustering by region and country. Latin
American sequences are in shades of red, South East Asian sequences are in shades of blue, and South and Central Asian sequences are in shades of
green.
doi:10.1371/journal.pntd.0002796.g007
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to pvmsp-1, we found that pvcsp variants demonstrate strong
evidence of geographic clustering. This juxtaposition between
pvmsp-1 and pvcsp sequences is similar to what has previously been
described for merozoite and sporozoite antigens in P. falciparum
[94]. The population sets included in this survey were collected in
different years. While it is known that novel P. vivax surface antigen
types can appear in the course of a decade [57], it is difficult to
assess the magnitude of this effect on our analyses. As more pvmsp-
1 and pvcsp population sets are collected, this will become clearer.
It is interesting that the CR of pvcsp shows evidence of multiple
forms of selection: (1) the depressed number of non-synonymous
mutations suggests purifying selection, (2) the differences in CR
genotypes between geographic locations suggests directional
selection, and (3) the genetic composition of the repeats suggests
rapid expansion and contraction, possibly due to immune
selection. It is unclear what drives the first two signatures of
selection. We hypothesize a model in which purifying selection
within a population limits the amino acid composition of repeats
due to functional constraints of the protein, while directional
selection between populations is driven by environmental factors.
One environmental factor that may explain both the purifying
and directional selection of parasite pvcsp CR sequences is the
mosquito vector. The circumsporozoite protein is expressed in the
mosquito during oocyst development [95] and in the salivary
glands [96,97]. It is also critical in sporozoite motility [15]. We
found no overlap in the distribution of Anopheline species between
the countries from Asia and Latin America included in this study
(data not shown) [98–100]. Furthermore, there is substantial
evidence that different Anopheline species and strains show
differential ability to be infected by malaria [101–104].
Regardless of the cause of the differing patterns of geospatial
genetic diversity we observed in pvmsp-1 and pvcsp, the
observation itself has significance for vaccine design. The
malaria vaccine field is just beginning to unravel how antigenic
diversity within a single parasite population can reduce vaccine
efficacy [105]. Our findings highlight an additional level of
complexity that will hinder the implementation of a vivax
vaccine – antigenic variability. While the effects of immune
cross-reactivity against different antigenic variants aren’t fully
known, the extensive intrapopulation variability seen in pvmsp-
1 may necessitate a highly multivalent pvmsp-1 vaccine, while
the dramatic interpopulation variability seen in pvcsp suggests
that a PvCSP-based vaccine that is effective in one part of the
globe may not be effective in other regions. Thus, a thorough
understanding of the geospatial genetic diversity of candidate
vaccine antigens must inform antigen selection for vaccine
design.
GenBank accession numbers
pvcsp sequences: JX461243-JX461285 and KJ173797-
KJ173802
pvmsp-1 sequences: JX461286-JX461333
Figure 8. Neighbor-joining tree of pvcsp VK247 repeat arrays. All repeat array haplotypes from each pvcsp VK247 population set were plotted
on a single unrooted, neighbor-joining phylogenetic tree. Latin American sequences are in shades of red, South East Asian sequences are in shades of
blue.
doi:10.1371/journal.pntd.0002796.g008
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Supporting Information
Figure S1 Geographic distribution of P. vivax popula-
tions contributing to this study. In total, we identified 13
populations with pvmsp-1 42 kDa fragment sequences and 13
populations with pvcsp central repeat or whole-gene sequences.
These populations were collected from 14 countries, pictured
above. For countries with n$10 isolates, the total number of
pvmsp-1 and pvcsp isolates is marked.
(TIF)
Figure S2 FST values at polymorphic sites within the
pvmsp-1 42 kDa intervening region. Available parasite
populations with n.25 individuals (Cambodia, India, NW
Thailand, S Thailand, and Turkey) share 42 variable sites within
the 42 kDa intervening region of pvmsp-1. FST values for each
variable site were calculated in a pairwise manner between all
five populations. FST values approaching 0 indicate limited
inter-population variability at that site, while values approaching
1 indicate substantial inter-population variability. Coordinates are
reported for every third polymorphic site.
(TIF)
Table S1 pvmsp-1 and pvcsp sequences included in this
study. The PlasmoDB gene identifier is PVX_099980 for pvmsp-1
and PVX_119355 for pvcsp. *Indicates the year the sequences were
made available in GenBank. {Indicates study unpublished but
sequences available in GenBank.
(DOCX)
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